Navigation Links
Sucampo Pharmaceuticals Announces Exercise and Closing of IPO Over-Allotment Option
Date:8/29/2007

BETHESDA, Md., Aug. 29 /PRNewswire-FirstCall/ -- Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) today announced that the underwriters for its initial public offering have exercised in full their option to purchase 562,500 shares of Sucampo's class A common stock to cover over-allotments and that the closing of that purchase took place on August 29, 2007. All of the shares sold at today's closing were sold by a selling stockholder and Sucampo did not receive the proceeds from that sale. Together with the 3,750,000 shares of class A common stock sold at the initial closing on August 7, 2007, the shares sold today bring the total number of shares sold in the offering to 4,312,500.

Cowen and Company, LLC acted as the book-running manager for the offering and CIBC World Markets Corp. and Leerink Swann & Company acted as co-managers.

About Sucampo Pharmaceuticals, Inc.

Sucampo is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones for the treatment of gastrointestinal, respiratory, vascular and central nervous system diseases and disorders. To learn more about Sucampo and its products, visit http://www.sucampo.com

Ronald Kaiser

Chief Financial Officer

Sucampo Pharmaceuticals, Inc.

301-961-3400

rkaiser@sucampo.com

or

Scott Solomon

Vice President

Sharon Merrill Associates, Inc.

617-542-5300

'/>"/>

SOURCE Sucampo Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IK,Iceland,November24/PRNewswire-FirstCall/--deCOD...hasreceivednoticefrom,theNasdaqStockMarketthattrad...vember30,2009andaForm25-NSEwillbefiledwiththe,Secu...scommonstock,fromlistingonNasdaq,unlessthecompanyf....Thecompanyhasfiledsuchanappeal,which,willstaythes...
(Date:11/24/2009)... Health care employment grew by 29,000...ne to show consistent growth during the U.S. reces...ain in trouble, and health systems are coming clos...stead of just administrators. , ...ployment continued growing in October despite the ...
(Date:11/24/2009)...I,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.a...lowedthepatentapplicationfor,itsnano-particleorald...hlyefficientapproachtoincorporatepeptidesor,protei...ryofdrugs,otherwiseadministeredasinjections.NODtec...ymacromoleculardrugssuchasinsulin,interferon,grow...
(Date:11/24/2009)...I,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounce...hasapprovedthe,investigationalnewdrugapplication(I...nsulinformulationtotreatdiabetes.ThisIND,approvala... , Diabetesisadisordercharacteristicofhighblo...etesoftenresultinseveremicro-and,macro-vasculardis...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...ollowing was issued,today by the Greater Baltimore...O, Greater Baltimore Committee, 140 company owner...rea,bioscience community, WHAT:, The third annua...N:, Tuesday, March 18, 2008, 8:00 a.m. / Breakfa...ram, WHERE:, Renaissance Harborplace Hotel, 202 ...
...rocess, Drive Value from Appraisals, OTTAWA, Marc...ng,provider of web-based employee performance and ... has been selected by Quiznos to provide a system,...adquarters. Quiznos is a,national chain with over ...usy consumers who are looking for a tasty, fresher...
...d Support of National Electronic Disease ...Calif., March 17 Computer,Sciences Corporation (N...ed a,task order from the Centers for Disease Contr... supporting the National Electronic Disease,Survei...m helps the CDC,manage and enhance public health s...
Other Biology Technology:Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18 2Quiznos Selects Halogen for Fresh Approach to Talent Management 2CSC Continues Support of Centers for Disease Control and Prevention Through New Task Order 2
(Date:11/25/2009)... may be just as vital to your health as what you e...ological Studies. Their experiments in mice reveal...f genes in the liverthe body,s metabolic clearingh... the body,s circadian clock as conventional wisdom...vity of a large number of genes completely indepen...
(Date:11/24/2009)...and flabby arteries from collapsing have been true...re no longer needed -- once the arteries are stren...ors had no choice but to leave them in place. , ...partment of Biomedical Engineering has developed a...ugs where they,re needed, then dissolves. , "Our...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 1AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 2AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 3DC 3A Muslim Coalition to Host Interfaith Hearing on Health Care 59326 1DC 3A Muslim Coalition to Host Interfaith Hearing on Health Care 59326 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 1Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 3Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 4Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 5Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 6Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 7Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 8
...g bones, a healthy immune system, protection again...ere,s yet another item for the expanding list of v...n," keeps the heart, the body,s long-distance runn...gan pharmacologist Robert U. Simpson, Ph.D., think...er." , In studies in rats, Simpson and his team ...
...11, 2008 The J. David Gladstone Institutes today ..., MD, PhD, also of Kyoto University and UCSF, has ...ntributions in reprogramming adult skin cells to p...eive half of the $1 million award. Cloning pioneer...er half of the prize for their landmark generation...
...ational May Concern Law Enforcement Departments, ...ulletin Board: STIY), the leader in electro-stun t...sting law enforcement departments that,have purcha...ade their,weapons in for Stinger S-200 electronic ...ssions., Ron Bellistri, Stinger,s CEO, stated, "I...
Other Biology News:Vitamin D: New way to treat heart failure? 2Vitamin D: New way to treat heart failure? 3Gladstone's Shinya Yamanaka wins prestigious Shaw Prize 2Stinger Systems To Offer Taser Trade-In Program 2
Mouse Anti-Xanthine Oxidase Prediluted Monoclonal Antibody, Unconjugated, Clone SPM325 from Abcam
Mouse Anti-Vancomycin Monoclonal Antibody, Unconjugated, Clone 2G1 from Abcam
Mouse Anti-14-3-3 Binding Motif, phospho (Ser) Monoclonal Antibody, Unconjugated, Clone 4E2 from Cell Signaling Technology
Endotoxin Free Water from Mo Bio Laboratories, Inc.
Biology Products: